Celldex Therapeutics (CLDX) is a clinical-stage biotechnology company that focuses on developing targeted therapies for rare and difficult-to-treat diseases, specializing in immuno-oncology and ...
Scalp rash occurred in 17% of patients, typically appearing later in treatment. Despite the high frequency of dermatologic adverse events, dose reductions due to rash or paronychia were infrequent, ...